Suppr超能文献

身体机能状态可预测接受起搏器植入术的老年患者的死亡率。

Physical performance status predicts mortality in aging patients undergoing pacemaker implantation.

作者信息

Balla Cristina, Passarini Giulia, Bonsi Beatrice, Pavasini Rita, Tonet Elisabetta, Malagú Michele, Campo Gianluca, Bertini Matteo

机构信息

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2021 Oct 1;22(10):738-743. doi: 10.2459/JCM.0000000000001209.

Abstract

AIMS

To assess whether frailty or reduced physical performance status may have an impact on clinical outcomes after pacemaker implantation in aging patients.

METHODS

A prospective cohort of patients aged more than 70 years, admitted to the hospital for pacemaker implantation, was enrolled. Patients were evaluated with the Short Physical Performance Battery (SPPB) and Handgrip Strength Test at hospital discharge and at 1 year. Overall mortality was the primary study endpoint.

RESULTS

Out of the 119 patients, the majority (71%) of patients had reduced physical performance (defined by an SPPB score <10 points). After a median follow-up of 46 months, the mortality was 31% of the population. SPPB value at discharge predicted death even after adjusting for pertinent confounders (adjusted hazard ratio 0.91, 95% confidence interval (CI) 0.84-0.99, P = 0.02). Patients with a poorer SPPB score at discharge (SPPB 0-3) had also an increased risk of death or rehospitalization at 1 year compared with patients with highest SPPB score (odds ratio OR 4.05, 95% CI 1-16.6).

CONCLUSION

Reduced physical performance is associated with increased mortality in aging patients with bradyarrhythmia requiring pacemaker implantation. The identification of patients with poor SPPB may tailor specific interventions to improve physical performance and outcomes after pacemaker implantation.The trial was registered in clinicaltrial.gov with the identifier NCT02386124.

摘要

目的

评估衰弱或身体机能下降状态是否会对老年患者起搏器植入后的临床结局产生影响。

方法

纳入一组年龄超过70岁、因起搏器植入入院的前瞻性队列患者。在出院时及1年时,采用简短体能状况量表(SPPB)和握力测试对患者进行评估。总死亡率是主要研究终点。

结果

119例患者中,大多数(71%)患者身体机能下降(定义为SPPB评分<10分)。中位随访46个月后,总体死亡率为31%。即使在调整相关混杂因素后,出院时的SPPB值仍可预测死亡(调整后的风险比为0.91,95%置信区间(CI)为0.84 - 0.99,P = 0.02)。出院时SPPB评分较差(SPPB 0 - 3)的患者与SPPB评分最高的患者相比,1年内死亡或再次住院的风险也更高(优势比OR为4.05,95% CI为1 - 16.6)。

结论

身体机能下降与需要植入起搏器的老年缓慢性心律失常患者死亡率增加相关。识别SPPB评分低的患者可能有助于制定特定干预措施,以改善起搏器植入后的身体机能和结局。该试验已在clinicaltrial.gov注册,标识符为NCT02386124。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验